MALIGNANT GENITOURINARY SYSTEM NEOPLASM
Clinical trials for MALIGNANT GENITOURINARY SYSTEM NEOPLASM explained in plain language.
Never miss a new study
Get alerted when new MALIGNANT GENITOURINARY SYSTEM NEOPLASM trials appear
Sign up with your email to follow new studies for MALIGNANT GENITOURINARY SYSTEM NEOPLASM, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Poop pills? stool transplants may ease immunotherapy side effects
Disease control Recruiting nowThis early-stage trial tests whether a stool transplant (FMT) can help cancer patients who develop severe diarrhea or colon inflammation from immune-checkpoint inhibitor drugs. About 40 patients with various cancers will receive the transplant via colonoscopy. The main goal is to…
Matched conditions: MALIGNANT GENITOURINARY SYSTEM NEOPLASM
Phase: PHASE1 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 11:03 UTC
-
Are cancer surgeons missing a key step to prevent deadly clots?
Knowledge-focused Recruiting nowThis study surveys 500 surgeons and advanced practice providers across the U.S. to see how often they prescribe blood thinners after cancer surgery to prevent dangerous blood clots. The goal is to understand current practices and find ways to improve care. No new treatments are b…
Matched conditions: MALIGNANT GENITOURINARY SYSTEM NEOPLASM
Sponsor: Wake Forest University Health Sciences • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:05 UTC
-
Could a poop transplant fix cancer treatment side effects?
Knowledge-focused Recruiting nowThis study looks at how the bacteria in your gut might cause stomach issues like diarrhea and colitis when you take certain cancer drugs called immune checkpoint inhibitors. Researchers will collect stool, blood, and tissue samples from 800 people with melanoma, lung cancer, or g…
Matched conditions: MALIGNANT GENITOURINARY SYSTEM NEOPLASM
Phase: PHASE1 • Sponsor: M.D. Anderson Cancer Center • Aim: Knowledge-focused
Last updated Jun 27, 2026 11:01 UTC